Based on these results, low levels of GP5 can increase the risk of IS, which is consistent with the association with Parkinson’s disease but contrary to the association with colorectal cancer, systemic lupus erythematosus, and dyslipidemia [18, 43]. This evidence concerns the gene GP5 and systemic lupus erythematosus.